With a revenue increase of 2.57% in the first quarter 2026, year on year to cumulative value of $48,482 million, Bristol Myers Squibb's revenue per employee grew on a trailing twelve months basis to $ 1,491,754, this marks a new company high.
Within the Healthcare sector Employees of 5 other companies have achieved higher revenue per employee. While Bristol Myers Squibb's total ranking has deteriorated compared to the previous quarter from 117 to 128. Bristol Myers Squibb has 32,500 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BMY Revenue per Employee	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Revenue Change	2.57 %	1.3 %	2.77 %	0.56 %	-5.6 %
Sales per Employee (TTM) $	1,491,754	1,482,892	1,477,969	1,467,815	1,465,723
BMY's Total Ranking	# 128	# 117	# 163	# 176	# 57
Seq. Revenue Change	-8.1 %	2.29 %	-0.38 %	9.53 %	-9.24 %

BMY Company Profile >> Back to BMY Efficiency Comparisons >> Compare BMY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 3
Healthcare Sector	# 6
Overall Market	# 128

Revenue per Employee Statistics
High	Average	Low
$ 1,491,754	$ 832,380	$ 486,338
(Mar 31 2026)		(June 30. 2013)

Financial Statements
Bristol Myers Squibb's Revenue MRQ	$ 11,489 Millions	Visit BMY's Income Statement
Bristol Myers Squibb's Revenues TTM	$ 48,482 Millions	Visit BMY's aggregate revenue growth
What are BMY's Sales?		Visit BMY's Sales by Segment

Other Ratios
Bristol Myers Squibb's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BMY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BMY's Competitors
Revenue per Employee for BMY's Suppliers
Revenue per Employee for BMY's Customers

You may also want to know
BMY's Sales Growth Rates	BMY's Pe Price to earnings ratio	BMY's Receivables Turnover Ratio	BMY's Stock Quote
BMY's Net Income Growth Rates	BMY's Ps Price to Sales ratio	BMY's Sales per Employee	BMY's Asset Turnover Ratio
BMY's Net Margin	BMY's Pb Price to Book ratio	BMY's Financial Strength Ratios	BMY's Dividend Payout Ratio

Date modified: 2026-07-06T19:32:40+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2026	Number of Employees Mar 31 2026
Innoviva Inc	2,479,150.94	$ 394.185 Million	159
Spero Therapeutics Inc	2,447,440.00	$ 61.186 Million	25
Aurinia Pharmaceuticals Inc	2,330,429.69	$ 298.295 Million	128
United Therapeutics Corporation	2,264,142.86	$ 3,169.800 Million	1,400
Elite Pharmaceuticals Inc	2,261,542.74	$ 147.000 Million	65
Anaptysbio Inc	2,234,500.00	$ 232.388 Million	104
Exelixis Inc	2,071,047.08	$ 2,375.491 Million	1,147
Kiniksa Pharmaceuticals International Plc	2,060,232.24	$ 754.045 Million	366
Cormedix Inc	2,040,572.14	$ 389.749 Million	191
Biocryst Pharmaceuticals Inc	2,036,128.74	$ 885.716 Million	435
Eton Pharmaceuticals Inc	1,968,500.00	$ 86.614 Million	44
Assertio Holdings inc	1,927,509.43	$ 102.158 Million	53
Siga Technologies Inc	1,913,809.53	$ 93.777 Million	49
Prestige Consumer Healthcare Inc	1,909,785.96	$ 1,088.578 Million	570
Zevra Therapeutics Inc	1,886,442.62	$ 115.073 Million	61
Incyte Corporation	1,885,028.13	$ 5,361.020 Million	2,844
Privia Health Group Inc	1,832,456.77	$ 2,246.592 Million	1,226
Tg Therapeutics Inc	1,755,260.65	$ 700.349 Million	399
Gilead Sciences Inc	1,749,176.47	$ 29,736.000 Million	17,000
Collegium Pharmaceutical Inc	1,747,635.93	$ 739.250 Million	423
Rigel Pharmaceuticals Inc	1,722,798.85	$ 299.767 Million	174
Alnylam Pharmaceuticals Inc	1,714,769.20	$ 4,286.923 Million	2,500
Atara Biotherapeutics Inc	1,681,428.57	$ 23.540 Million	14
Xenetic Biosciences Inc	1,595,036.50	$ 3.190 Million	2
Soleno Therapeutics Inc	1,565,978.02	$ 285.008 Million	182
Neurocrine Biosciences Inc	1,551,200.00	$ 3,102.400 Million	2,000
Jazz Pharmaceuticals Plc	1,535,863.32	$ 4,438.645 Million	2,890
Mirum Pharmaceuticals Inc	1,531,206.99	$ 569.609 Million	372
Agenus Inc	1,529,209.88	$ 123.866 Million	81
Progyny Inc	1,510,233.64	$ 1,292.760 Million	856

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.